Log in to your Inderes Free account to see all free content on this page.
Senzime
4.77 SEK
-1.14 %
Less than 1K followers
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.14 %
-15.12 %
-26.16 %
-7.92 %
-13.27 %
-16.32 %
-58.80 %
-78.02 %
-19.62 %
Senzime operates in the medical technology industry and focuses on the development and manufacture of systems for monitoring and diagnostics in healthcare. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. The company's products are aimed at healthcare institutions and physicians. The operations are global. Senzime was founded in 1999 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
749.92M SEK
Turnover
606.96K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
18.2.
2026
Annual report '25
22.4.
2026
Interim report Q1'26
19.5.
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Senzime to Present at Redeye and BioStock Investor Conferences
Nomination Committee for Senzime Annual General Meeting 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio